\-\ Texto\\:\\ \ \(0\)\
\-\ bilateral\\ hip\\ pain\ \(11\)\
\-\ patient\\ is\\ continued\\ on\\ medical\\ management\\ and\\ will\\ likely\\ need\\ hip\\ replacements\\ relatively\\ early\ \(0\)\
\-\ subchondral\\ sclerosis\\ and\\ collapse\\ with\\ cyst\\ formation\\ in\\ both\\ femoral\\ heads\\.\ \(0\)\
\-\ contour\\ abnormality\\ in\\ both\\ femoral\\ heads\\ \\(flattening\\)\ \(1\)\
\-\ avn\ \(0\)\
\-\ avn\ \(0\)\
\-\ active\\ duty\\ man\\ with\\ hip\\ pain\\.\ \(0\)\
\-\ evaluation\\ in\\ total\\ joint\\ clinic\ \(0\)\
\-\ report\\ of\\ avn\\ in\\ both\\ hips\ \(0\)\
\-\ avn\\ in\\ \\ a\\ young\\,\\ active\\ duty\\ male\\ is\\ often\\ associated\\ with\\ steroid\\ use\\.\\ \\ other\\ potential\\ causes\\ in\\ this\\ patient\\ include\\ trauma\\,\\ infection\\ and\\ caisson\\ dz\\.\\ \\ chronic\\/inflamatory\\ causes\\ such\\ as\\ sickle\\ cell\\ disease\\,\\ lupus\\,\\ gaucher\\'s\\ dz\\ or\\ radiation\\ therapy\\ are\\ much\\ less\\ likely\\ in\\ a\\ service\\ member\\ on\\ active\\ duty\\.\\ \ \(0\)\
\-\ although\\ cases\\ as\\ advanced\\ as\\ this\\ are\\ clearly\\ visible\\ on\\ plain\\ film\\,\\ avn\\ is\\ best\\ evaluated\\ on\\ mr\\ imaging\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ avn\\:\\ 0\\.5362039593471306\ \(0\)\
\-\ duty\\:\\ 0\\.25516072788077465\ \(0\)\
\-\ dz\\:\\ 0\\.22352895890759744\ \(0\)\
\-\ hip\\:\\ 0\\.20671308310940154\ \(0\)\
\-\ active\\:\\ 0\\.19982533614698825\ \(0\)\
\-\ heads\\:\\ 0\\.19347887463395183\ \(0\)\
\-\ in\\:\\ 0\\.15619919319495418\ \(0\)\
\-\ both\\:\\ 0\\.15006150516663744\ \(0\)\
\-\ causes\\:\\ 0\\.13555665853779045\ \(0\)\
\-\ femoral\\:\\ 0\\.1333357915277483\ \(0\)\
\-\ member\\:\\ 0\\.12374883239458023\ \(0\)\
\-\ replacements\\:\\ 0\\.12164910369827511\ \(0\)\
\-\ caisson\\:\\ 0\\.11814025900729393\ \(0\)\
\-\ gaucher\\:\\ 0\\.10979633819641471\ \(0\)\
\-\ on\\:\\ 0\\.1083624066870006\ \(0\)\
\-\ as\\:\\ 0\\.10810567164796055\ \(0\)\
\-\ likely\\:\\ 0\\.10720366805884116\ \(0\)\
\-\ hips\\:\\ 0\\.09448923276243573\ \(0\)\
\-\ lupus\\:\\ 0\\.09347438986904434\ \(0\)\
\-\ service\\:\\ 0\\.09283248004057718\ \(0\)\
\-\ sickle\\:\\ 0\\.08870690504162215\ \(0\)\
\-\ flattening\\:\\ 0\\.08846683003960971\ \(0\)\
\-\ steroid\\:\\ 0\\.08645670048708197\ \(0\)\
\-\ subchondral\\:\\ 0\\.08583997017910815\ \(0\)\
\-\ clearly\\:\\ 0\\.08448855922969796\ \(0\)\
\-\ advanced\\:\\ 0\\.08430464359876497\ \(0\)\
\-\ collapse\\:\\ 0\\.08412285420773628\ \(0\)\
\-\ need\\:\\ 0\\.08257492273117657\ \(0\)\
\-\ contour\\:\\ 0\\.08072283076205394\ \(0\)\
\-\ potential\\:\\ 0\\.0801509638431091\ \(0\)\
\-\ visible\\:\\ 0\\.07906607804019537\ \(0\)\
\-\ much\\:\\ 0\\.07768694223989762\ \(0\)\
\-\ evaluated\\:\\ 0\\.07664211915212792\ \(0\)\
\-\ clinic\\:\\ 0\\.07555723334921417\ \(0\)\
\-\ report\\:\\ 0\\.07555723334921417\ \(0\)\
\-\ young\\:\\ 0\\.07396350518943355\ \(0\)\
\-\ is\\:\\ 0\\.07369394380251573\ \(0\)\
\-\ continued\\:\\ 0\\.07349686539232972\ \(0\)\
\-\ total\\:\\ 0\\.07349686539232972\ \(0\)\
\-\ relatively\\:\\ 0\\.07304367531736936\ \(0\)\
\-\ best\\:\\ 0\\.07217469140304013\ \(0\)\
\-\ formation\\:\\ 0\\.07111236601603092\ \(0\)\
\-\ use\\:\\ 0\\.068632066662144\ \(0\)\
\-\ are\\:\\ 0\\.06807329159949228\ \(0\)\
\-\ film\\:\\ 0\\.06702939690740199\ \(0\)\
\-\ management\\:\\ 0\\.06625638723229232\ \(0\)\
\-\ abnormality\\:\\ 0\\.06524517128095093\ \(0\)\
\-\ early\\:\\ 0\\.06465776621134639\ \(0\)\
\-\ pain\\:\\ 0\\.06419512120576752\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0638905600451375\ \(0\)\
\-\ this\\:\\ 0\\.06164430160563489\ \(0\)\
\-\ although\\:\\ 0\\.0610652797955597\ \(0\)\
\-\ less\\:\\ 0\\.0610236251826235\ \(0\)\
\-\ cases\\:\\ 0\\.060331875036081783\ \(0\)\
\-\ radiation\\:\\ 0\\.05944193039414993\ \(0\)\
\-\ plain\\:\\ 0\\.059180780262981195\ \(0\)\
\-\ joint\\:\\ 0\\.059106955680488085\ \(0\)\
\-\ often\\:\\ 0\\.05852851410443022\ \(0\)\
\-\ patient\\:\\ 0\\.058349085906182166\ \(0\)\
\-\ mr\\:\\ 0\\.058039264638378066\ \(0\)\
\-\ will\\:\\ 0\\.05773259952427621\ \(0\)\
\-\ such\\:\\ 0\\.05769889188609935\ \(0\)\
\-\ medical\\:\\ 0\\.05700722698418296\ \(0\)\
\-\ and\\:\\ 0\\.05560552664160214\ \(0\)\
\-\ evaluation\\:\\ 0\\.05470340966994017\ \(0\)\
\-\ infection\\:\\ 0\\.05418331432959542\ \(0\)\
\-\ include\\:\\ 0\\.05337001744004625\ \(0\)\
\-\ with\\:\\ 0\\.052692486813557295\ \(0\)\
\-\ trauma\\:\\ 0\\.052093686012946935\ \(0\)\
\-\ cyst\\:\\ 0\\.051743976851365135\ \(0\)\
\-\ therapy\\:\\ 0\\.051537824642035705\ \(0\)\
\-\ cell\\:\\ 0\\.05131189249110912\ \(0\)\
\-\ bilateral\\:\\ 0\\.048207488542620296\ \(0\)\
\-\ man\\:\\ 0\\.04748770123114077\ \(0\)\
\-\ associated\\:\\ 0\\.047278036695787576\ \(0\)\
\-\ imaging\\:\\ 0\\.04713979750051028\ \(0\)\
\-\ other\\:\\ 0\\.04658206892873192\ \(0\)\
\-\ male\\:\\ 0\\.039937392314234196\ \(0\)\
\-\ disease\\:\\ 0\\.03765240360130826\ \(0\)\
\-\ or\\:\\ 0\\.03120464343345093\ \(0\)\
\-\ of\\:\\ 0\\.017553673955180354\ \(0\)\
